Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate/vilanterol versus fluticasone furoate in pediatric asthma
CTR20181312Phase 3Active
- Sponsor
- GSK
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate + vilanterol, fluticasone in asthma, sponsored by GSK. Started May 2019; status: active.
02
Drugs
fluticasone propionate + vilanterolfluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20181312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181312.